» Articles » PMID: 25142104

Glycaemic Regulation and Insulin Secretion Are Abnormal in Cystic Fibrosis Pigs Despite Sparing of Islet Cell Mass

Abstract

Diabetes is a common and significant co-morbidity in cystic fibrosis (CF). The pathogenesis of cystic fibrosis related diabetes (CFRD) is incompletely understood. Because exocrine pancreatic disease is similar between humans and pigs with CF, the CF pig model has the potential to contribute significantly to the understanding of CFRD pathogenesis. We determined the structure of the endocrine pancreas in fetal, newborn and older CF and non-CF pigs and assessed endocrine pancreas function by intravenous glucose tolerance test (IV-GTT). In fetal pigs, pancreatic insulin and glucagon density was similar between CF and non-CF. In newborn and older pigs, the insulin and glucagon density was unchanged between CF and non-CF per total pancreatic area, but increased per remnant lobular tissue in CF reflecting exocrine pancreatic loss. Although fasting glucose levels were not different between CF and non-CF newborns, CF newborns demonstrated impaired glucose tolerance and increased glucose area under the curve during IV-GTT. Second phase insulin secretion responsiveness was impaired in CF newborn pigs and significantly lower than that observed in non-CF newborns. Older CF pigs had elevated random blood glucose levels compared with non-CF. In summary, glycaemic abnormalities and insulin secretion defects were present in newborn CF pigs and spontaneous hyperglycaemia developed over time. Functional changes in CF pig pancreas were not associated with a decline in islet cell mass. Our results suggest that functional islet abnormalities, independent of structural islet loss, contribute to the early pathogenesis of CFRD.

Citing Articles

Fatty acid abnormalities in cystic fibrosis-the missing link for a cure?.

Drzymala-Czyz S, Walkowiak J, Colombo C, Alicandro G, Storrosten O, Kolsgaard M iScience. 2024; 27(11):111153.

PMID: 39620135 PMC: 11607544. DOI: 10.1016/j.isci.2024.111153.


Endocrine pathology in young rabbits with cystic fibrosis.

Liang X, Hou X, Chen Y, Jin J, Zhang K, Xu J eGastroenterology. 2024; 2(4).

PMID: 39605883 PMC: 11594368. DOI: 10.1136/egastro-2024-100102.


Pancreatic Crosstalk in the Disease Setting: Understanding the Impact of Exocrine Disease on Endocrine Function.

Villaca C, Mastracci T Compr Physiol. 2024; 14(2):5371-5387.

PMID: 39109973 PMC: 11425433. DOI: 10.1002/cphy.c230008.


Cystic fibrosis-related metabolic defects: crosstalk between ion channels and organs.

Sims-Lucas S, Goetzman E, Kleyman T J Clin Invest. 2024; 134(13).

PMID: 38949023 PMC: 11213462. DOI: 10.1172/JCI182329.


Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes.

Malik S, Padmanabhan D, Hull-Meichle R Front Endocrinol (Lausanne). 2023; 14:1269139.

PMID: 38075070 PMC: 10704027. DOI: 10.3389/fendo.2023.1269139.


References
1.
Oppenheimer E, ESTERLY J . Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases. Perspect Pediatr Pathol. 1975; 2:241-78. View

2.
Borowitz D, Durie P, Clarke L, Werlin S, Taylor C, Semler J . Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2005; 41(3):273-85. DOI: 10.1097/01.mpg.0000178439.64675.8d. View

3.
Lanng S, Thorsteinsson B, Roder M, Orskov C, Holst J, Nerup J . Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh). 1993; 128(3):207-14. DOI: 10.1530/acta.0.1280207. View

4.
Kraemer R, Rudeberg A, HADORN B, Rossi E . Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand. 1978; 67(1):33-7. DOI: 10.1111/j.1651-2227.1978.tb16273.x. View

5.
Longnecker D . Pathology and pathogenesis of diseases of the pancreas. Am J Pathol. 1982; 107(1):99-121. PMC: 1915993. View